$诺瓦瓦克斯医药(NVAX)$ 8-K - Current report Filed: 2019-08-01 AccNo: 0001144204-19-037216 Size: 44 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接